Serveur d'exploration sur la visibilité du Havre

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Clinical and bacteriological evaluation of sisomicin in sixteen cases of severe bronchopulmonary infection

Identifieur interne : 002B50 ( Main/Exploration ); précédent : 002B49; suivant : 002B51

Clinical and bacteriological evaluation of sisomicin in sixteen cases of severe bronchopulmonary infection

Auteurs : H. Duwoos [France] ; C. Guyonnaud [France] ; J. Nouveau [France] ; P. Carpentier [France] ; C. Abderhalden [France]

Source :

RBID : ISTEX:BE90984CE11F933541CA4767D333FB431061C343

Abstract

Summary: Sisomicin, an aminoglycoside antibiotic, was used as sole bactericidal therapy in sixteen cases of severe bronchopulmonary infection for an average of 11.5 days (range 7 to 14) with a dose of 3.5 mg/kg per day in three intramuscular injections. Fifteen of these hospitalized patients presented with chronic airway obstruction which resulted in lowered O2 saturation (SaO2-86.1%, range 74 to 93) and, in twelve patients, hypercapnia (PaCO2=55.7 torr, range 33–73). Two of these patients were under continuous assisted ventilation. Two patients had a lower lobe infiltrate and a lung abcess respectively. Proteus (n=3), Pseudomonas (n=9), K. pneumoniae (n=2), E.coli (n=1), Enterobacter (n=1), S. aureus (n=1) and D. pneumoniae (n=1) were the dominant organisms in the bronchial secretions isolated by Mulder's method; P. aeruginosa was associated with K. pneumoniae, P. rettgeri and E.coli respectively in three cases. In thirteen cases, either a clinical cure (n=2) or a definite improvement was observed (sputum volume and purulence, auscultatory signs, temperature). However, among these patients were three cases of superinfection/colonization and two cases of persistent organisms. In addition, in two of the three cases showing no improvement colonization occurred. The favorable results of this study appear to be due to vigorous antibiotic therapy combined with intensive adjunct therapy. No adverse local or systemic reactions clearly attributable to the drug were observed.

Url:
DOI: 10.1007/BF01646987


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Clinical and bacteriological evaluation of sisomicin in sixteen cases of severe bronchopulmonary infection</title>
<author>
<name sortKey="Duwoos, H" sort="Duwoos, H" uniqKey="Duwoos H" first="H." last="Duwoos">H. Duwoos</name>
</author>
<author>
<name sortKey="Guyonnaud, C" sort="Guyonnaud, C" uniqKey="Guyonnaud C" first="C." last="Guyonnaud">C. Guyonnaud</name>
</author>
<author>
<name sortKey="Nouveau, J" sort="Nouveau, J" uniqKey="Nouveau J" first="J." last="Nouveau">J. Nouveau</name>
</author>
<author>
<name sortKey="Carpentier, P" sort="Carpentier, P" uniqKey="Carpentier P" first="P." last="Carpentier">P. Carpentier</name>
</author>
<author>
<name sortKey="Abderhalden, C" sort="Abderhalden, C" uniqKey="Abderhalden C" first="C." last="Abderhalden">C. Abderhalden</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:BE90984CE11F933541CA4767D333FB431061C343</idno>
<date when="1976" year="1976">1976</date>
<idno type="doi">10.1007/BF01646987</idno>
<idno type="url">https://api.istex.fr/document/BE90984CE11F933541CA4767D333FB431061C343/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000805</idno>
<idno type="wicri:Area/Istex/Curation">000805</idno>
<idno type="wicri:Area/Istex/Checkpoint">001693</idno>
<idno type="wicri:doubleKey">0300-8126:1976:Duwoos H:clinical:and:bacteriological</idno>
<idno type="wicri:Area/Main/Merge">002C30</idno>
<idno type="wicri:Area/Main/Curation">002B50</idno>
<idno type="wicri:Area/Main/Exploration">002B50</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Clinical and bacteriological evaluation of sisomicin in sixteen cases of severe bronchopulmonary infection</title>
<author>
<name sortKey="Duwoos, H" sort="Duwoos, H" uniqKey="Duwoos H" first="H." last="Duwoos">H. Duwoos</name>
<affiliation wicri:level="3">
<country xml:lang="fr">France</country>
<wicri:regionArea>Pneumologie et Réanimation respiratoire, Hôpital Calmette, F-76083, Le Havre Cedex</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Région Normandie</region>
<region type="old region" nuts="2">Haute-Normandie</region>
<settlement type="city">Le Havre</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Guyonnaud, C" sort="Guyonnaud, C" uniqKey="Guyonnaud C" first="C." last="Guyonnaud">C. Guyonnaud</name>
<affiliation wicri:level="3">
<country xml:lang="fr">France</country>
<wicri:regionArea>Pneumologie et Réanimation respiratoire, Hôpital Calmette, F-76083, Le Havre Cedex</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Région Normandie</region>
<region type="old region" nuts="2">Haute-Normandie</region>
<settlement type="city">Le Havre</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Nouveau, J" sort="Nouveau, J" uniqKey="Nouveau J" first="J." last="Nouveau">J. Nouveau</name>
<affiliation wicri:level="3">
<country xml:lang="fr">France</country>
<wicri:regionArea>Pneumologie et Réanimation respiratoire, Hôpital Calmette, F-76083, Le Havre Cedex</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Région Normandie</region>
<region type="old region" nuts="2">Haute-Normandie</region>
<settlement type="city">Le Havre</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Carpentier, P" sort="Carpentier, P" uniqKey="Carpentier P" first="P." last="Carpentier">P. Carpentier</name>
<affiliation wicri:level="1">
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Medical Research, Schering USA</wicri:regionArea>
<wicri:noRegion>Schering USA</wicri:noRegion>
<wicri:noRegion>Schering USA</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Abderhalden, C" sort="Abderhalden, C" uniqKey="Abderhalden C" first="C." last="Abderhalden">C. Abderhalden</name>
<affiliation wicri:level="3">
<country xml:lang="fr">France</country>
<wicri:regionArea>Centre de Biologie Médicale, rue Sery, F-76600, Le Havre</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Région Normandie</region>
<region type="old region" nuts="2">Haute-Normandie</region>
<settlement type="city">Le Havre</settlement>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Infection</title>
<title level="j" type="sub">A Journal of INFECTIOUS Disease</title>
<title level="j" type="abbrev">Infection</title>
<idno type="ISSN">0300-8126</idno>
<idno type="eISSN">1439-0973</idno>
<imprint>
<publisher>Springer-Verlag</publisher>
<pubPlace>Berlin/Heidelberg</pubPlace>
<date type="published" when="1976-12-01">1976-12-01</date>
<biblScope unit="volume">4</biblScope>
<biblScope unit="supplement">4</biblScope>
<biblScope unit="page" from="S475">S475</biblScope>
<biblScope unit="page" to="S482">S482</biblScope>
</imprint>
<idno type="ISSN">0300-8126</idno>
</series>
<idno type="istex">BE90984CE11F933541CA4767D333FB431061C343</idno>
<idno type="DOI">10.1007/BF01646987</idno>
<idno type="ArticleID">BF01646987</idno>
<idno type="ArticleID">Art38</idno>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0300-8126</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass></textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Summary: Sisomicin, an aminoglycoside antibiotic, was used as sole bactericidal therapy in sixteen cases of severe bronchopulmonary infection for an average of 11.5 days (range 7 to 14) with a dose of 3.5 mg/kg per day in three intramuscular injections. Fifteen of these hospitalized patients presented with chronic airway obstruction which resulted in lowered O2 saturation (SaO2-86.1%, range 74 to 93) and, in twelve patients, hypercapnia (PaCO2=55.7 torr, range 33–73). Two of these patients were under continuous assisted ventilation. Two patients had a lower lobe infiltrate and a lung abcess respectively. Proteus (n=3), Pseudomonas (n=9), K. pneumoniae (n=2), E.coli (n=1), Enterobacter (n=1), S. aureus (n=1) and D. pneumoniae (n=1) were the dominant organisms in the bronchial secretions isolated by Mulder's method; P. aeruginosa was associated with K. pneumoniae, P. rettgeri and E.coli respectively in three cases. In thirteen cases, either a clinical cure (n=2) or a definite improvement was observed (sputum volume and purulence, auscultatory signs, temperature). However, among these patients were three cases of superinfection/colonization and two cases of persistent organisms. In addition, in two of the three cases showing no improvement colonization occurred. The favorable results of this study appear to be due to vigorous antibiotic therapy combined with intensive adjunct therapy. No adverse local or systemic reactions clearly attributable to the drug were observed.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>France</li>
</country>
<region>
<li>Haute-Normandie</li>
<li>Région Normandie</li>
</region>
<settlement>
<li>Le Havre</li>
</settlement>
</list>
<tree>
<country name="France">
<region name="Région Normandie">
<name sortKey="Duwoos, H" sort="Duwoos, H" uniqKey="Duwoos H" first="H." last="Duwoos">H. Duwoos</name>
</region>
<name sortKey="Abderhalden, C" sort="Abderhalden, C" uniqKey="Abderhalden C" first="C." last="Abderhalden">C. Abderhalden</name>
<name sortKey="Carpentier, P" sort="Carpentier, P" uniqKey="Carpentier P" first="P." last="Carpentier">P. Carpentier</name>
<name sortKey="Guyonnaud, C" sort="Guyonnaud, C" uniqKey="Guyonnaud C" first="C." last="Guyonnaud">C. Guyonnaud</name>
<name sortKey="Nouveau, J" sort="Nouveau, J" uniqKey="Nouveau J" first="J." last="Nouveau">J. Nouveau</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/France/explor/LeHavreV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002B50 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002B50 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/France
   |area=    LeHavreV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:BE90984CE11F933541CA4767D333FB431061C343
   |texte=   Clinical and bacteriological evaluation of sisomicin in sixteen cases of severe bronchopulmonary infection
}}

Wicri

This area was generated with Dilib version V0.6.25.
Data generation: Sat Dec 3 14:37:02 2016. Site generation: Tue Mar 5 08:25:07 2024